American drug maker Gilead Sciences is expanding clinical trials of its investigational antiviral drug, remdesivir, for the treatment of the novel coronavirus (COVID-19) into several Asian countries outside China, including Taiwan, in March, according to a statement issued by the biotechnology company.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Cold weather to continue but Tomb Sweeping Festival will be warmer
03/30/2025 08:32 PM - Society
Civic groups highlight struggles of female migrant workers, Palestine
03/30/2025 08:26 PM - Society
Taiwan Red Cross to donate US$50,000 to earthquake-hit Myanmar
03/30/2025 07:26 PM - Society
Kenting guesthouse to be fined for exceeding price rise limit
03/30/2025 07:03 PM - Politics
U.S., Japan defense chiefs take note of PLA activates around Taiwan
03/30/2025 06:56 PM